Sage Journals: Discover world-class research

Retricted access

Research article

First published 2017-4

Reimbursement changes and drug switching: are severe patients more affected?

Shou-Hsia Cheng, Chi-Chen Chen, Hung-Chih Kuo [...]

Journal of Health Services Research & Policy

Retricted access

Research article

First published 2015-5

The Effects of State Pharmacy Drug Product Selection Laws on Statin Patient Generic-To-Branded Drug Switch-Backs

George A. Chressanthis, Nayla G. Dahan, Kevin J. Fandl

The American Economist

Retricted access

Research article

First published 2012-3

Content Analysis of Television Advertising for Drugs That Switch From Prescription to Over-the-Counter

Adrienne E. Faerber, David H. Kreling

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 1994-4

Adequacy of FDA'S Prescription to over-the-Counter Switch Criteria in Physician Evaluation of Proposed Switches of Drug Products *

Suresh Madhavan

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2010-09

Proactive Planning of the Timing of a Partial Switch of a Prescription to Over‐the‐Counter Drug

Gila E. Fruchter, Murali K. Mantrala

Production and Operations Management

Retricted access

Research article

First published 2004-01

Drug Switching: The Bottom Line Isn’t Always What It Seems

David L. Whaley, Curtis M. Warren, David L. Thomas

Journal of Correctional Health Care

Retricted access

Research article

First published 2022-01

Uptake Success and Cost Savings from Switching to a Two-Drug Antiretroviral Regimen

Hartmut B. Krentz, Shayna Campbell, Morgan Lahl [...]

AIDS Patient Care and STDs

Open access

Research article

First published 2023

Drug switching in axial spondyloarthritis patients in Germany – a social listening analysis

Maria Kahn, Steffeni Papukchieva, Axel Fehr [...]

Therapeutic Advances in Musculoskeletal Disease

Retricted access

Research article

First published 1994-3

Switch Drugs Vis-à-Vis Rx and OTC: Policy,Marketing,and Research Considerations

Mariea Grubbs Hoy

Journal of Public Policy & Marketing

Retricted access

Other

First published 1985-4

Criteria Used by the FDA to Determine What Classes of Drugs are Appropriate Switch Candidates

Peter H. Rheinstein

Therapeutic Innovation & Regulatory Science

Search results